首页> 美国卫生研究院文献>Filaria Journal >Systemic insecticide treatment of the canine reservoir of Trypanosoma cruzi induces high levels of lethality in Triatoma infestans a principal vector of Chagas disease
【2h】

Systemic insecticide treatment of the canine reservoir of Trypanosoma cruzi induces high levels of lethality in Triatoma infestans a principal vector of Chagas disease

机译:系统性杀虫剂治疗克氏锥虫犬的水库可导致Trigasa infestans(南美锥虫病的主要媒介)致死率高

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundDespite large-scale reductions in Chagas disease prevalence across Central and South America, Trypanosoma cruzi infection remains a considerable public health problem in the Gran Chaco region where vector-borne transmission persists. In these communities, peridomestic animals are major blood-meal sources for triatomines, and household presence of infected dogs increases T. cruzi transmission risk for humans. To address the pressing need for field-friendly, complementary methods to reduce triatomine infestation and interrupt T. cruzi transmission, this study evaluated the systemic activity of three commercial, oral, single dose insecticides Fluralaner (Bravecto®), Afoxolaner (NexGard®) and Spinosad (Comfortis®) in canine feed-through assays against Triatoma infestans, the principal domestic vector species in the Southern Cone of South America.
机译:背景尽管中美洲和南美洲的南美锥虫病患病率大规模降低,但在媒介传播仍然持续存在的大查科地区,克氏锥虫感染仍然是一个相当大的公共卫生问题。在这些社区中,腹膜动物是三氟精胺的主要血粉来源,受感染的犬只在家庭中的存在会增加克氏锥虫对人类的传播风险。为了满足对减少三松散虫侵染和中断克鲁氏锥虫传播的现场友好补充方法的紧迫需求,本研究评估了三种商业,口服,单剂量杀虫剂Fluralaner(Bravecto®),Afoxolaner(NexGard®)和Spinosad(Comfortis®)在针对Triatoma infestans(南美洲南锥体的主要家养媒介物种)的犬直通试验中。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号